The present invention relates to compounds which are prodrugs of one of: atenolol, atomoxetine, desipramine, diclofenac, duloxetine, enalapril, fluoxetine, metoprolol, mecamylamine, pramipexole, rasagiline, salbutamol, tamsulosin, vildagliptin, varenicline, clozapine, olanzapine, desloratadine, methylphenidate, dexmethylphenidate and peroxetine
Prodrugs of secondary amine compounds